• Display of Biologics
• Engineering Antibodies
• Machine Learning Part 2

• Antibody-Based Therapies
• Emerging Targets
• Membrane Protein Targets

• Safety & Efficacy
• Advancing Multispecifics
• Engineering Bispecifics

• Immunoengineering
• Innovative CAR Therapy
• Next-Gen Immunotherapies

• Optimisation & Developability
• Analytical Characterisation
• Protein Stability & Formulation

• Leveraging Data Science
• Optimising Expression
• Developing Workflows

• Intro to Machine Learning
• Machine Learning Part 1
• Machine Learning Part 2

• Antibody-Based Therapies
• Engineering ADCs
• Next-Gen Immunotherapies

Related Event